Next Post

European Commission grants marketing authorisation to Valneva's COVID-19 shot

[ad_1] The symbol of French-Austrian biotech business Valneva is seen exterior their headquarters in Vienna, Austria, December 16, 2021. REUTERS/Lisi Niesner Sign up now for Absolutely free unrestricted accessibility to Reuters.com Sign-up June 24 (Reuters) – French drugmaker Valneva’s (VLS.PA) COVID-19 vaccine has gained advertising authorisation from the European Commission […]